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EXECUTIVE SUMMARY 
 
Along with the socio-economic transformation after 1990, the research and development (R&D) 
system underwent a substantial size reduction. In recent years, the Czech Republic is catching up 
with advanced European countries; however, the lag remains significant, especially in R&D 
outputs, such as top quality scientific publications and international patents. R&D expenditures 
along with the numbers of researchers, doctoral graduates and tertiary students have increased 
steadily over the last decade. Yet most of the relevant indicators have not reached the EU27 
average.  
 
In 2011, gross domestic expenditure on R&D (GERD) amounted to €2.9b with a slight 
predominance of private funding over the public one. Despite the current economic crisis and 
major slowdown of economic growth, R&D intensity of the economy in terms GERD as % of 
GDP noticeably increased in recent years from the bottom of 1.41% in 2008 to 1.84% in 2011; 
hence getting somewhat closer to the target of 2.7% outlined in the Europe 2020 initiative. A 
clear trend of the recent years is the growth of business and foreign R&D funding, while public 
resources earmarked to R&D tend to stagnate (Eurostat, 2013a).  
 
The Czech Republic has a strong public research system based on a developed network of public 
universities and research institutes. However, a major weakness of the public research sector has 
traditionally been limited commercialization of the outputs. The R&D evaluation system did not 
motivate researchers to cooperate with the business sector. This problem has been addressed by 
the Reform of the research, development and innovation (RDI) System and National Research, 
Development and Innovation Policy 2009-2015. Unfortunately, the results have been 
disappointing so far. 
 
Based on the latest economic trends, the national innovation performance as well as on national 
strategic documents dealing with RDI policy, and strengths and weaknesses of the system, the 
following main structural challenges and relevant policy measures were identified: 
 
 Inefficient use of public funds for supporting R&D and innovation. To tackle this problem, it is 
necessary to introduce of a complex methodology for evaluation of R&D results; the 
current one based predominantly on quantitative indicators has been identified as 
unsatisfactory; the necessity to update the evaluation methodology has been 
emphasized in the International Audit of Czech R&D; however, the revision requires 
consensus of the key players in the national R&D system, which proved extremely 
difficult to achieve, especially if redistribution of public funds between sectors is at 
stake.  
 Lack of external financial resources for innovation. The Technology Agency of the Czech 
Republic (TA CR) has been established in 2009 as the dominant supporter of applied 
research and launched a portfolio of new programmes; two programmes of the OP EI, 
Progress and Guarantee, help start-ups and micro enterprises to overcome the limited 
availability of external funding; however, availability of venture capital remains one of 
the lowest among EU27 countries; the Ministry of Industry and Trade (MIT) 
announced plans to establish a public seed fund financed from the OP EI to boost the 
access to venture capital. 
 Lack of public-private collaboration. The Operational Programme Research and 
Development for Innovation (OP RDI) supports building of the infrastructure for 
excellent fundamental and applied research and infrastructure for transfer of R&D 
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knowledge; clustering activities are supported through the Operational Programme 
Enterprise and Innovation (OP EI); there are new national R&D programmes that 
motivate enterprises to cooperate with research organisations in common projects. 
 Protection of intellectual property rights (IPRs) is underutilized and hence market for technology 
underdeveloped. Among the top objectives of the Reform of the RDI System is to 
improve the commercialization of R&D outputs on the market for technology and 
innovation processes at large; new R&D support programmes, such as Alpha and 
Competence Centres launched by TA CR, require the utilization of R&D results, and 
motivate the participants to acquire IPRs; the sub-programme of the OP EI called 
Innovation enables beneficiaries to use the grant on IPRs; however, the number of 
international patents per capita remains low. 
 Future funding of new large R&D infrastructures. Six major projects with a total subsidy of 
€835m, most of which comes from the OP RDI, are under construction. After five 
years, wage, maintenance and other operating expenses must be covered from other 
sources than the EU structural funds. Private funding is likely to cover only a small 
fraction. Unless the government significantly expands the amount of public R&D 
support, which is not likely to happen given the daunting budgetary pressures, there 
could be painful trade-offs at stake. Either the new projects or the existing 
infrastructure might need to shrink. It is not clear how this situation is going to be 
resolved. 
 
Recently identified policy mix routes and their recent development include the following: 
 
 Stimulating innovative entrepreneurship. New measures (e.g. pre-seed fund supported by the 
OP RDI and a seed fund financed from the OP EI) should be launched in 2013 in line 
with the implementation of the Strategy of International Competitiveness. 
 Boosting R&D investment in established firms. The TIP and Alpha programmes 
administered by the MIT and TA CR, respectively, are the prime sources of public 
support for business R&D. Also parts of the OP EI are relevant to this issue. Finally, 
there is the tax credit scheme. 
 Attracting R&D-performing firms from abroad.  The system of investment incentives run 
under the Ministry of Industry and Trade (MIT) through CzechInvest has been 
recently focused on targeting R&D intensive projects. Foreign investors are allowed to 
use both direct and indirect fiscal support for R&D and acquire funds from European 
programmes. 
 Upgrading the public R&D infrastructure. The OP RDI provides a significant amount of 
money for enhancing R&D capacity in the public sector; in particular, six large R&D 
infrastructures projects, which are going to have a profound impact on the whole R&D 
system, have been approved recently. 
 More business R&D carried out in cooperation with research organizations. The TIP and Alpha 
programmes support co-operation of research organizations and firms. The 
Competence Centres programme launched by the TA CR is entirely devoted to 
promoting long-term partnerships between research organisations and the business 
sector. Also the large R&D projects currently being built with the support of the OP 
RDI are required to seek private co-financing.  
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Generally speaking, the above-mentioned challenges, policy mix routes and measures are aligned 
with the European Research Area’s (ERA) objectives, despite in some respects the policy 
response has been piecemeal. National Research and Innovation Strategy on Smart Specialisation 
(RIS3), including 14 regional RIS3 strategies at the NUT3 level, is at an early stage of 
development, despite a need to embrace the RIS3 principles rather soon. Nevertheless, either 
way, the RDI policy mix in the following years is likely to concentrate on the support of 
innovative companies, RDI human resources development including the mobility issues, 
international as well as inter-sectoral co-operation in research, securing the sustainability of the 
large research infrastructures and the design of a new evaluation methodology of R&D results, 
which should lead to more effective distribution of RDI funds. 
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1 INTRODUCTION  
 
The Czech Republic is a small and open Central European country with land area of 77.3 square 
kilometres and population of 10.5 million people, accounting for 1.8% and 2.1% of the EU27 
total, respectively. In 2011, gross domestic product (GDP) per capita in purchasing power 
standards (PPS) reached €20,200, 80% of the EU27 average. After real GDP dropped in the 
peak of the crisis by 4.5% in 2009, the economy slowly recovered by 2.5% and 1.9% in 2010 and 
2011; however the positive trend reverted, as there is expected to be yet another decline by 1.3% 
in 2012 (Eurostat, 2013b).  
 
Despite the sluggish economy, R&D intensity in terms of gross domestic expenditure on R&D 
(GERD) as % of GDP increased from the crisis bottom of 1.41 % in 2008 to 1.84% in 2011, 
getting significantly closer to the EU27 average of 2.03% but staying far from the national 
Europe 2020 target of 2.7%. In 2011, the business sector financed 47% of GERD, of which 
98% was spend by the firms themselves, which testifies to their weak link to the rest of the 
system. Business enterprise expenditure on R&D (BERD) as % of GDP expanded to 1.11% in 
2011 compared to 0.96% in 2010, approaching the EU27 average of 1.26%. In 2011, the 
government sector financed 37% and foreign sources accounted for 15% of GERD, the latter 
doubling from only 7% in 2008, which makes funding from abroad the most dynamic source 
(Eurostat, 2013a). 
 
As far as R&D outputs, such as internationally recognized publications and patents, are 
concerned, there are several high-profile fields, which stand out in any ranking, including organic 
chemistry, nuclear physics, medical sciences, machine tools, measuring and testing, textile 
materials, electrical engineering, combustion engines and vehicles in general. Nevertheless, the 
Czech R&D system still lags far behind the top EU countries in terms of R&D outputs per 
capita, although the productivity is slowly catching up with the EU-27 average.  
 
At the heart of the public R&D sector is the Academy of Sciences of the Czech Republic 
(ASCR), consisting of 54 research institutes, and 23 public, 2 state and 39 private universities. 
Unlike in Western Europe, research activities are concentrated under the umbrella of the ASCR, 
the primary mission of which is to conduct basic research, while the higher education sector has 
been traditionally less research-oriented and more focused on teaching. However, this has started 
to change in recent years, as the ASCR tends to get more involved in applied research and the 
university sector expands research activities. 
 
In 2008, the Reform of the research, development and innovation (RDI) system was launched. 
The Reform profoundly changed the governance of the RDI policy and the responsibilities of 
the main players. More specifically, competences of particular governmental bodies in RDI 
policy are given by the Act No. 130/2002 Coll. on the Support of Research and Development 
from Public Funds and by the Reform amendment announced as Act. no 211/2009 Coll. As the 
result, the main players in RDI policy making are as follows: 
 
Council for Research, Development and Innovation (CRDI) is an expert and advisory 
government body for RDI policy with 17 members chaired by the Prime Minister. At the 
political level, the CRDI plays the main strategic and coordinating role in the governance system.  
 
Ministry of Education, Youth and Sports (MEYS) is the central administrative authority for 
R&D programmes in the public sector, particularly institutional funding for public universities. 
MEYS coordinates the EU Structural Funds through the Operational Programme Research and 
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Development for Innovation (OP RDI) and the Operational Programme Education for 
Competitiveness (OP EC). 
 
Ministry of Industry and Trade (MIT) is responsible for policies in the domain of business R&D 
and innovation. MIT coordinates the EU Structural Funds through Operational Programme 
Enterprise and Innovation (OP EI). 
 
Technology Agency of the Czech Republic (TA CR) provides competitive funding for applied 
research and experimental development. 
 
Czech Science Foundation (GA CR) provides funding for competitive grants in basic research. 
 
Academy of Sciences of the Czech Republic (ASCR) is a conglomerate of 54 formally 
independent public research institutes, which together represent by far the most important 
public research performer. 
 
Figure 1: Overview of Czech Republic’s research system governance structure  
 
Source: ERAWATCH Research and Innovation Inventory (2013) 
 
 
RDI policy making is fairly centralized. Regional authorities, the self-governing regions at the 
NUTS-III level, do not have any legally binding responsibilities in this respect. At the regional 
level, the role of RDI policy is limited to coordination of the national programmes and the 
implementation of regional development policies. Nonetheless, the law does not prevent the 
regional authorities from launching their own RDI policy initiatives, though only a very few have 
done so. 
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2 RECENT DEVELOPMENTS OF THE 
RESEARCH AND INNOVATION POLICY 
AND SYSTEM  
 
2.1 National economic and political context 
 
 
Real GDP growth was high for nearly a decade, annually on average about 4.5% over 2000-2008, 
which was well above the EU27 average. However, the slump in export demand during the 
global economic crisis hit the economy hard and GDP dropped by 4.5% in 2009; despite the fact 
that the domestic financial sector did not face major difficulties thanks to the cleanup about a 
decade ago. In 2010 and 2011, the economy recovered at a slow pace with GDP growing by 
2.5% and 1.9%, respectively, however only to plunge into a double dip recession, as in 2012 
according to Eurostat’s prediction GDP is expected to decline by 1.3% again (Eurostat, 2013b).  
 
The center-right government spearheaded by the Prime Minister Petr Nečas has been 
significantly reshuffled since mid-2011. Most importantly, heads of the two core ministries 
involved in RDI policy making, i.e. MEYS and MIT, have been changed. Petr Fiala, professor of 
political sciences and the former dean of the Faculty of Social Studies at the Masaryk University, 
has replaced Josef Dobeš in the helm of the MEYS in May 2012. Martin Kuba, physician and the 
former first deputy of the regional government in South Bohemia region, has replaced Martin 
Kocourek as the head of the MIT in November 2011. Also there were major changes in the 
composition of the CRDI Council in 2011. However, this has not been accompanied by a major 
shift in RDI policies. 
 
2.2 Funding trends 
 
In 2011, gross domestic expenditure on R&D (GERD) amounted to €2.9b and increased by 
about one fifth as compared to the previous year, driven mainly by the expansion of business 
and foreign funding, which represents the highest annual growth recorded in five years and a 
promising signal of recovery in R&D spending. As the consequence, R&D intensity of the 
economy in terms of GERD as % of GDP increased to 1.84% in 2011, as compared to 1.41 % 
at the dawn of the crisis in 2008, hence noticeably approaching the EU27 average of 2.03% 
according to the latest available Eurostat’s estimate. However, the R&D intensity of the 
economy is still far from the target of 2.7% outlined in the Europe 2020 initiative (Eurostat, 
2013a). 
 
Business enterprise expenditure on R&D (BERD) accounted for 60% (€1.73b) of the total, the 
higher education sector came second with 22% (€0.62b) closely followed by the public research 
institutions with 18% (€0.50b), while the private non-profit sector remained negligible 
accounting for less than 1% (€0.01b) in 2011. BERD as % of GDP reached 1.11% in 2011, 
which represents a significant increase compared to 0.96% in 2010, the crisis bottom of 0.87% in 
2008, and about 0.70% ten years ago. BERD is characterised by a level of domination by foreign-
owned companies that is one of the highest in the EU, as nearly 60% is performed by foreign 
affiliates, which represents a particular challenge for the design of RDI policies (Eurostat, 2013a). 
 
In 2011, the business sector financed 47% (€1.35b) of GERD, of which 98% was spend by the 
firms themselves, most of the remaining 2% went to the public research institutions and only 
slightly less than 0.5% flew to the higher education sector, which testifies to the very weak link 
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between the business sector and other parts of the system. The government sector funded 37% 
of GERD (€1.06b), most which became split between higher education (42%) and public 
research institutions (37%). Foreign sources contributed by 15% (€0.44b) of GERD funding, 
doubling from only 7% in 2008, about 40% of which came from private and 60% from public 
foreign sources; predominantly the EU funds, which is a major shift as the private segment 
dominated in previous years (Eurostat, 2013a). 
 
Government budgetary appropriations or outlays for R&D (GBAORD) amounted to €1.05b and 
the intensity of the economy in terms of GBAORD as % of GDP reached 0.68% in 2001, which 
represents a significant increase from 0.53% of GDP in 2008, hence largely narrowing the gap as 
compared to the EU27 average of 0.73%, despite major cuts in other parts of the government 
budget (Eurostat, 2013a). However, GBAORD are expected to stagnate at €1.06b and 0.69% of 
GDP in 2012. Likewise, the amount of GBAORD approved in the 2013 public budget and 
earmarked by the government for the years 2014 and 2015 has been frozen at about €1.03b 
(CRDI, 2012a). Hence, GBAORD is likely to stay at roughly the same level in foreseeable future. 
 
 
 2009 
 
2010 2011 EU27 
 
GDP growth rate 
 
-4.5 2.5 1.9 - 0.3 (2012) 
GERD (% of GDP) 
 
1.47 1.55 1.84 2.03s (2011) 
GERD (euro per capita) 200.0 222.2 273.0 510.5s (2011) 
 
GBAORD - Total R&D appropriations (€ 
million) 
870.3 893.9 1,048.3 91,277.1 (EU27 total 
2011) 
R&D  funded by Business Enterprise Sector 
(% of GDP)  
0.66 0.76 0.86 1.26 (2011) 
R&D performed by HEIs  (% of GERD) 
 
18.1 18.0 21.6 24% (2011) 
R&D performed by Government Sector (% of 
GERD) 
 
21.4 19.4 17.5 12.7% (2011) 
R&D performed by Business Enterprise 
Sector (% of GERD) 
 
60.0 62.0 60.3 62.4% (2011) 
Share of competitive vs institutional public 
funding for R&D (% of GBAORD) 
44.2 46.5 48.1 n/a 
s - EUROSTAT estimate 
Data Source: EUROSTAT (2013a) and (CRDI 2012a), March 2013. 
 
 
The Czech system of public R&D funding has been traditionally dominated by institutional 
support. However, this is changing in the context of the Reform of the RDI System. As the 
result, the share of institutional funds in GBAORD decreased in the last few years, namely from 
56% in 2009 to 52% in 2011. According to the GBAORD plans approved by the government, 
the share of institutional funding should continue to decrease to 51% in 2012, 50% in 2013 and 
further drop to 47% in 2014 and 2015. The largest share of institutional funding is distributed 
between the ASCR and the MEYS which, in turn, forward the money to individual recipients, 
predominantly public research institutes and universities (CRDI, 2012a).  
 
In 2012, the single largest recipient of institutional funds is earmarked to be the ASCR with 
CZK4.5b (€179m), which constitutes the vast majority of its annual budget and about 33% of 
the total institutional funding. In 2013, the budget of the ASCR and the respective proportions 
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are planned to remain roughly the same. It is interesting to note that a part of this funding is re-
distributed between the public research institutes within the ASCR based on its own internal 
methodology, and hence its own policy in this respect. Overall, however, the largest share of the 
institutional funding, about 56% and CZK7.5b (€300m) in 2012 and 54% and CZK6.9b (€276m) 
in 2013, is channelled by the MEYS. Much smaller amounts are channelled through other 
ministries which provide institutional funding mainly to research centres controlled by them (the 
Ministry of Agriculture, the Ministry of Culture, the Ministry of Health and others). 
 
The main providers of project-based funding of a bottom-up type, i.e. competitive research 
grants driven by the intentions of applicants, are the GA CR which allocates grants for basic 
research and the TA CR which supports applied research and experimental development. GA 
CR has an annual budget of CZK 3.0b (€120m) and CZK 3.3b (€132m) in 2013. The legal 
statute of TA CR was adopted by the government in December 2009 and the first programme 
Alpha was launched in March 2010. The first projects were selected in November 2010 and 
started at the beginning of 2011. Another three programmes funded by TA CR called Beta, 
Omega and Competence Centres were launched during 2011-2012. As the result, the budget of 
TA CR has grown significantly in recent years. In 2011, the budget was CZK 0.9b (€34m). In 
2012, the approved budget reached CZK 2.2b (€86m). In 2013, the budget is earmarked to 
further increase to CZK 2.6b (€102m).  
 
Yet a major part of project funding for applied research is still administered by the MIT, 
primarily through the TIP research programme with a budget of CZK 3.0b (€121m) in 2012, 
which however has been significantly reduced in the medium-term budget plans and hence is 
going to expire in the coming years. As soon as this programme is finished, MIT is supposed to 
cease the administration competitive R&D funding and completely pass this role to the TA CR. 
Also the MEYS has a significant budget devoted to project-based funding, which is consumed 
primarily by the higher education sector, namely CZK 3.5b (€140m) in 2011, CZK 2.6b (€103m) 
in 2012 and CZK 2.8b (€113m) in 2013.  
 
Much smaller amounts are channelled by five other ministries which provide competitive 
funding through their individual research programmes (the Ministry of Agriculture, the Ministry 
of Culture, Ministry of Defence, Ministry of Health and Ministry of Interior). As past experience 
has shown, however, these programmes while nominally competitive funds are often used as a 
source of institutional funding for some selected research institutes controlled by the given 
ministries and also as a means of research funding for the needs of the respective ministries. 
 
Thematic funding programmes are underdeveloped and the thematic focus is not very strongly 
promoted by the existing funding sources. Nonetheless, some thematic programmes do exist in 
competence of several ministries such as the Ministry of health, the Ministry of Culture etc. 
Hence, the share of public resources spent on thematically non-oriented research far exceeds 
expenditures on oriented research. According to the shares of socio-economic objectives 
(NABS), non-oriented research had 25.6% share on GBAORD in 2011, followed by the research 
financed from general university funds with 30.4% share. Within thematically oriented research, 
representing the remaining 44.0% of GBAORD, prevails industrial research (14.8% of the total 
GBAORD), followed by medical research (6.1%), agricultural research (4.0%) and research in 
the field of energy production, distribution and utilisation (3.2%). Other socio-economic 
objectives have a combined share of 16% on the total GBAORD (CZSO, 2012a). 
 
The role of the EU structural funds in the funding of R&D has grown enormously in the new 
programming period 2007-2013. Public R&D activities are financed particularly by two OPs 
administered by the MEYS: OP RDI (ERDF) and OP EC (ESF). The combined allocation of 
these two OPs equals approximately €3.8b. Business R&D and innovation activities are financed 
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through the OP EI administered by the MIT with a total budget of approximately €3b for RDI 
relevant activities. Innovation activities with only a small fraction of possible R&D financing are 
also supported by the OP Prague -Competitiveness (OP PC). By February 2013, Czech 
participants active in projects funded under the 7th Framework Programme acquired support of 
€209m from the EU (total project costs of €286m), participating in 893 projects (Technology 
Centre ASCR, 2013). 
 
Finally, R&D tax credit scheme, hence indirect fiscal R&D support, to stimulate private R&D 
efforts has been launched in 2005. The new tax regulation enabled enterprises to deduct 
expenditures on R&D carried out for their own needs from their tax base, a major change as 
there was no measure of this kind before. In 2005, 27% of R&D active businesses used the tax 
relief. In 2010, the number of companies drawing on indirect support to R&D was already 35% 
of companies performing R&D activities, the total indirect support of R&D reached almost 
CZK 1.33b (€54m) and the tax deductible amounted to CZK 7.0b (€285m). By far the highest 
share of R&D active firms, which use the indirect support, is in the group of small enterprises up 
to 50 employees; hence this instrument proves to be particularly suitable for promoting R&D in 
small firms (Peroutková, 2012).  
 
 
2.3 New policy measures 
 
In 2012, three new programmes managed by TA CR were launched: i) BETA is  a programme of 
public procurement in research, experimental development and innovation for the needs of 
public administration bodies, approved for the period 2012 to 2016 and with a budget of €26m 
over the five years; ii) OMEGA supports applied social science research and experimental 
development, is approved for the period 2012 –2017 and the budget is only a little over €2.5 
million in the first year;  and iii) Competence Centres supports RDI centres in progressive fields 
with strong application potential and with conditions for the development of long-term 
collaboration between the public and private sectors, approximately 35 centres are supported 
with a budget of about €240m over 2012 to 2019.  
 
On 20 December 2012, the government approved an action plan for 71 measures to promote 
growth, entrepreneurship and employment. The measures are organized in five key areas: i) 
Reduction of regulatory burden; ii) Strengthening of competitiveness and extending tax credits; 
iii) Support for innovation; iv) Export promotion; and v) Efficient use of the EU funds. More 
specifically, the government aims to launch a new program promoting technical education, 
including lifelong learning, design a new program promoting applied research in the business 
sector, implement tax credit scheme to support cooperation of businesses with the sector of 
secondary and higher education and extend the existing R&D tax credits to purchase of external 
R&D services from research organizations. 
 
The MIT has announced plans to launch a pilot project of a public-private seed fund aimed at 
boosting the grossly underdeveloped national market for venture capital and supporting the 
creation of new knowledge-based companies, including university and research spin-offs. The 
pilot project has been presented at 15 universities during the autumn of 2012 and is expected to 
start in the second half of 2013. According to preliminary figures, a budget of approximately 
€53m is earmarked for the seed fund, most of which (about 85%) should come from OP EI and 
the rest from the state budget. 
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2.4 Recent policy documents  
 
In the context of the National Policy of RDI 2009-2015 implementation, new long-term national 
priorities of oriented RDI (for the period until 2030) were prepared by panels of experts at the 
end of 2011. More specifically, the priority research fields were identified within six broader 
areas: i) Knowledge Economy; ii) Energy; iii) Natural Resources; iv) Social Sciences; v) Health; 
and vi) Security Research. The identified set of priority research fields was approved by the 
government’s resolution no. 552 in July 2012. According to the resolution, the governmental 
ministries, ASCR, GA CR as well as TA CR have responsibility for implementing the priorities 
within their authority, namely during the preparation of new RDI programmes. Furthermore, the 
priorities will be taken into account during the update of the National RDI policy 2009-2015 and 
the preparation of proposal of state budget expenditures for 2014 and later.  
 
National Innovation Strategy of the Czech Republic (NIS) has been published in October 2011. 
The Resolution of the Government no. 77 of 26 January 2011 assigned the MIT and MEYS to 
prepare this document in line with recommendations of the Innovation Union (2010) strategy of 
the EU and as an integral part of the International Competitiveness Strategy of the Czech 
Republic (ICS). NIS was approved by the Government’s resolution no. 714 of 27 September 
2012. At the conceptual level the strategy indentifies four priority areas: i) Excellence in research; 
ii) Cooperation and knowledge transfer between academia and industry; iii) Support for 
innovative entrepreneurship; and iv) People as carriers of new ideas and initiators of change. The 
strategy provides a base for the forthcoming update of the National RDI Policy 2009-2015.  
 
 
2.5 Research and innovation system changes 
 
New large R&D infrastructure projects that are going to have a profound impact of the whole 
R&D system have been approved for funding in 2011 and 2012. By December 2012, six major 
projects with a total amount of subsidy of €835m (85% funded by the ERDF) were approved: i) 
ELI - Extreme Light Infrastructure (€271m); ii) BIOCEV - Biotechnology and Biomedicine 
Research Centre (€92m); iii) CEITEC - Central European Institute of Technology (€209m); iv) 
Centrum excelence IT4Innovations (€72)m; v) ICRC - International Clinical Research Center 
(€94m); and vi) Udrzitelna energetika (€97m). The projects are financed by the OP RDI, through 
the Priority Axes 1 and 2. For more information see the Annual Report on Implementation of 
the OP RDI for 2011 (MEYS, 2012). 
 
As the result of the implementation of the Reform of the RDI System, the number R&D budget 
providers have been halved to 11 in the budget period 2013-2015. The responsibility for 
administrating public support for applied research and innovation is moving under the umbrella 
of the TA CR, which gradually takes this responsibility over from ministries and other state 
institutions. Therefore, the budget of the TA CR grows, while the R&D budget earmarked for 
competitive funding of applied research of ministries declines, especially of the MIT, which used 
to be the main provider of funds for the support of industrial research. On the other hand, the 
MEYS and MIT administer large OPs of the EU structural funds dealing with R&D and 
innovation, therefore there is significant dynamics of expenditure within these programmes as 
the national public co-financing is required.  
 
 
  13 
2.6 Regional and/or National Research and Innovation Strategies on 
Smart Specialisation (RIS3) 
 
Regional authorities, consisting of 14 self-governing regions at the NUTS3 level, do not have any 
legally binding responsibilities in RDI policy. Yet the law does not prevent them from launching 
own RDI initiatives, which is, however, difficult given their restricted budgets. So far their main 
role has been in catalyzing the EU Structural Funds projects, primarily those funded from the 
OP RDI. South Moravian region is the main exception that proves the rule, representing the 
national role-model of regional innovation policy with dedicated authorities, well functioning 
innovation agency and dialogue with the business community; for more information see 
(RISJMK, 2013). Several other regions are attempting to emulate this model with various degrees 
of success, most prominently Moravia-Silesia, Liberec, Zlín and Hradec Králové regions, while 
most of the other regions have either only paid a lip service to developing regional innovation 
policy or ignored this policy area altogether, such as Central Bohemia, Vysočina and Plzeň 
regions. 
 
National RIS3 strategy, as an annex to which will be produced regional RIS3 strategies, is due to 
be announced by the end of 2013. MEYS has accepted the responsibility for designing the RIS3 
strategy and appointed a coordination board in November 2012. The national RIS3 facilitator 
and regional RIS managers are expected to be selected during the first half of 2013; thus arguably 
facing a very tight schedule. The regional managers will be appointed and funded by the MEYS, 
so there formally will be 14 regional attachments to the national RIS3 report, but it remains to be 
seen to which extent a top-down initiative of this kind will make a tangible difference on the 
ground, especially in the regions where indigenous initiative has been limited so far. Admittedly, 
only South Moravia and the Capital City of Prague have started to work on their RIS3 strategies 
in a genuinely bottom-up manner, independently of the national push; the testimony to which is 
the fact that only these two regions have registered in the S3 (Smart Specialisation Strategies) 
Platform initiative of the JRC by March 2013. 
 
RDI policy making is fairly centralized. So far co-ordination between the national and regional 
level innovation strategies has been very weak, if not missing altogether. National innovation 
strategy has addressed the regional aspects of innovation vaguely only. Drafting of the national 
RIS3 strategy involves, at least formally, a co-ordinated action of the national and regional 
authorities on the topic of innovation policy; hence representing a much needed opportunity for 
establishing a nation-wide debate on this topic. Needless to say, it is pertinent that this dialogue 
is sustained beyond this particular purpose and elements of multilevel governance of the RDI 
system are implemented in the future. 
 
 
2.7 Evaluations, consultations  
 
The International Audit of the RDI System of the Czech Republic (Arnold, 2011) carried out for 
the MEYS by Technopolis and MIOIR Manchester with the support of the Technology Centre 
of ASCR in 2010 and 2011. The main recommendations were presented in October 2011 as 
follows: i) The promised civil service reforms should urgently be carried out; ii) The state should 
continue to increase its investment in R&D; iii) The organisation, performance and division of 
labour among the universities, ASCR and RTOs should be reviewed; iv) Ministry capacities to 
act in RDI should be strengthened; v) R&D programming practice should respect the 
international tradition of stakeholder involvement; vi) Institutional funding should comprise at 
least 50% of research funding; vii) The evaluation methodology should be replaced by a system 
of performance contracts; viii) Evaluation practice should be the subject of root and branch 
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reform, refocusing on outcomes and impacts in addition to outputs; ix) CRDI should generate a 
RDI internationalisation strategy and x) The employers’ organisations or chambers of commerce 
should launch a campaign of IPR education for industry. 
 
 
2.8 Policy developments related to Council Country Specific 
Recommendations  
 
Recent debates about the need to reduce the share of institutional funding in favour of funds 
allocated for project funding distributed on a competitive basis has resulted in a proposal to 
reform the system of institutional funding. As a part of the Reform of the RDI System, it has 
been decided that each research organisation receives institutional funds based on its historical 
research results achieved over the past five years, as reported to the central database of research 
results. However, this new system of quality evaluation of higher education and research 
institutions has been hotly debated topic in recent years. It has been heavily criticized by the 
academic community for being too mechanistic and for not taking into account differences in 
publication (and citation) behaviour between different fields of science, among other things. It 
has been also criticized in the International Audit of Czech RDI, one of which recommendation 
was to fundamentally review the system and replace it by replaced by a system of performance 
contracts.  
 
As the result, this system of distribution the institutional funding has been largely abandoned in 
the budget period 2013-2015. More specifically, the formula used over this period is based on the 
compromise between the need to use quantitative criteria (as required by the law) and other 
considerations, as the results of which 80% of the money has been divided in the same way as in 
the 2011 budget and only 20% has been divided based on the historical research results achieved 
over the previous five years (CRDI, 2012a). Admittedly, the 80/20 division was a result of a 
negation between the respective stakeholders. Hence, in a way, the currently distribution of the 
funding is based on a consensus between the main policy actors, rather than on the quantitative 
data. A project (as a part of the OP RDI) intended to conduct more systematic revision of the 
methodology is in the making now. The results are expected sometimes in 2013. On the base of 
this should be adopted the new legislation as outlined din the CSR recommendations. 
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3 STRUCTURAL CHALLENGES FACING THE 
NATIONAL SYSTEM 
 
 
According to the Innovation Union Scoreboard 2011 (European Commission, 2012), the Czech 
Republic is classified in the “moderate innovators” category with the overall innovative 
performance below the EU-27 average. Nevertheless, the Czech Republic ranked on the 8th 
place in terms of the performance growth over the previous five years. Strengths are in Human 
resources (youth secondary education), Firm investments (non-R&D innovation expenditures), 
Innovators (non-technological innovation) and Economic effects (high-tech exports and 
innovative sales). Weaknesses are concentrated in Open, excellent and attractive research systems 
(top scientific publications and non-EU doctorate students), Finance and support (venture 
capital) and Intellectual assets (patents, trademarks, etc.). High growth is observed in tertiary 
education, trademarks and (from a very low base) in venture capital.  
 
Many analyses of the RDI system have been recently carried out in the context of the ongoing 
reform by (or in cooperation with) by the Technology Centre of ASCR, notably the International 
Audit of RDI in the Czech Republic summarized by Arnold (2011), which has pinned down the 
key policy challenges in the most comprehensive way so far. Moreover, there are the twin 
documents Competitiveness Report by the National Economic Council (2011) and Strategy of 
International Competitiveness by MIT (2011a), including the follow-up National Innovation 
Strategy produce jointly by MEYS and MIT (2011b), which scrutinize the role of RDI in the 
broader policy context. Drawing on their findings, which are by and large in parlance with results 
of European Commission (2012) and with each other, the main structural challenges can be 
summarized, not necessarily in the order of importance, in six areas as follows. 
 
Governance and public funding 
 
At the present time governance of the national system is undergoing a profound reform outlined 
in the National RDI Policy of the Czech Republic 2009–2015 (CRDI, 2009). RDI funding 
system has been streamlined. TA CR has been established as the dominant supporter of applied 
research. The role of ministries has been gradually reduced, especially in favour of the CRDI, 
GA CR and TA CR. The CRDI has centralised principal activities, become effectively 
responsible for setting the entire national research budget and de facto assumed the role of a 
science ministry. However, the CRDI formally continues to be an advisory body of the 
government only; without adequate executive administration, analytical capabilities and budget 
line, which inhibits its capacity to make informed decisions on long-term strategy development. 
The CRDI has become overburdened with responsibilities, which it struggles to cope with given 
the limited resources.  
 
A particularly thorny liability of the CRDI, which haunts the policy debate for several years, is 
the dysfunctional evaluation methodology of research institutions, which determines the 
allocation of public institutional funding. The current formula-based approach that has been 
implemented early in the reform automatically reallocates the entire flow of institutional funding 
annually based exclusively on outputs generated in the preceding five years.  The idea was to 
make the allocation performance-based, which in turn was expected to reward quality, boost 
productivity and de-politicise the funding process. But the methodology that has been put in 
place has been fiercely resisted by the stakeholders and criticized as simply “not fit for the 
purpose” by Arnold (2011) for falling into the trap of reductionism, creating inherent instability 
of the funding flows, failing to address differences between fields of science, stimulating 
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opportunistic behaviour, ignoring national thematic priorities and in general terms for focusing 
on immediate outputs at the expense of losing the sight of the intended societal effects.  
 
As the result, the strategic policy-making has been complicated, if not largely paralyzed, by fights 
among members of the CRDI over the evaluation methodology. More recently, the institutional 
funding flow has been refined for the budget period 2013-2015, by introducing a short-term 
patch into the formula that redirects the flows in a way agreed in political negotiations among the 
key stakeholders, which effectively means that the current system has been abandoned without 
replacing it by a new one. It is not clear what happens beyond this horizon. Overall, this 
stalemate locks the stakeholders in short-term focus and represents a major impediment for 
tackling many other problems that are intimately related to incentives laid down in the 
evaluation.  
 
Arnold (2011) concluded that the political instability in recent years had a major negative impact 
on the RDI system. There have been frequent changes of ministers that make it difficult to 
implement consistent policy. All too often, the reform debates have been politicised and the 
decision making process dominated by interest groups, not based on strategic intelligence and 
dealing with the problems in a systematic manner. Many of the unresolved issues are symptoms 
of a lack of trust among the key actors, especially the lack of trust in the government, which 
thwarts attempts to make deeper changes in the system. In the meantime, public RDI funding is 
expected to stagnate in the medium-term outlook, and hence unless there is a breakthrough, the 
prospects for reaching the 2020 national target of 1% of GBAORD as % of GDP remain rather 
bleak. 
 
RDI human resources 
 
The lack of highly skilled personnel is often cited as not only hampering the quality of research 
in PROs but even more so as the major obstacle of innovation in the private sector. According 
to the data from CZSO (2012b) and the assessment of MIT (2011b), the number of PhD 
graduates has stagnated in recent years, there is a long-term tendency for the proportion of 
science and technology tertiary students to decrease in comparison to those of social science and 
humanities, and because the reform of tertiary education remains uncompleted, there has been 
an unchecked expansion of university graduates over the last decade or so, the quality of which is 
however hard to judge.  As shown by National Training Fund (2012), moreover, opportunities 
for early career researchers are weak, post-doc funding remains limited and especially in the 
university sector often not allocated on competitive basis, which leads to in-breeding. Arnold 
(2011) reported that management of research groups is underdeveloped, the groups tend to be 
very small, locked into existing research trajectories, lacking interdisciplinarity and there is little 
use of career development plans; this is partly because of weak bottom-up incentives, lack of 
internationalisation strategies and poor mobility among researchers. Overall, the approach to 
RDI human resource management is unsystematic. 
 
Technological capabilities, multinationals and venture capital 
 
A major policy shift promoted by the RDI reform has been from a system traditionally focused 
on science towards more attention devoted to boosting innovation. But the success has been at 
best partial so far. Arnold lamented (2011) that the economy is based on diffusion and 
absorption of technologies that are new to the firm or new to the country but not new to the 
world and concluded that domestic knowledge generation has not been yet established as the 
main driver of growth. Most R&D done by enterprises is limited to experimental development 
rather than research. Almost 60% of business R&D is performed by foreign affiliates. As noted 
by MIT (2011b), however, foreign affiliates are largely doing low-added value work, even within 
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high-tech industries, as the parent companies tend to keep the core research activities close to 
their headquarters abroad. From this follows the challenge to make the multinationals more 
embedded in the national innovation system and upgrade the activities they perform locally.  
 
European Commission (2012) testifies to the fact that utilization to venture capital to support 
innovative businesses and spin-off firms trying to commercialize research outcomes is one of the 
lowest among European countries and that limited access to external sources of finance for 
innovation is perhaps the single most important obstacle for improving the innovative 
performance of indigenous firms. Unfortunately, a lack of experience among potential clients 
and rather traditional entrepreneurial culture do not form an environment favourable to venture 
capital expansion. Public support measures to boost access to venture capital remain completely 
missing; despite recurring plans to launch a public seed fund, which could kick-start the market, 
but which however has not been put into operation yet. Despite the business R&D spending has 
increased noticeably in recent years, the limited venture capital market makes this trend 
unsustainable, and unless this obstacle is addressed, the ambition of spending 2% of GDP on 
R&D, as delineated in the Horizon 2020 policy of the EU, is far out of reach. 
 
Public-private collaboration 
 
Public-private linkages are underdeveloped. Given the historical separation of science and 
business and the prevailing differences in culture or attitudes in these spheres, the lack of 
collaboration between them is one of the main issues in innovation policy. In spite of a steady 
effort to strengthen public-private links, deficiencies are present on both sides, namely poor 
commercialisation endeavour and limited industry-valuable results in the public sector on one 
hand and low ability to look outside the firm, identify and exploit knowledge in companies on 
the other hand. Since the business sector tends to lag behind the technology frontier, except 
perhaps of the dis-embedded multinationals, most of the firms focus on absorbing existing 
technologies rather than collaborating with science. Poor mobility of professionals between the 
sectors and sometime too rigid setting of support measures only reinforce the weaknesses.  
 
All too many public-private linkages are informal. MIT (2011b, pg. 7) account of this situation 
speaks volumes about the poor management of public-private linkages: “A very important 
mechanism of knowledge transfer in the Czech Republic is informal networks based on personal 
contacts. The problem is that collaboration happens between individuals and not between 
enterprises and research organizations. Hence, the outcome is often what can be described as 
“privatization of outputs of public research activities”. Research organizations suffer a loss of 
potentially significant source of income. Moreover, these issues generate personal conflicts in 
research teams. For many public researchers these informal linkages represent the main source of 
their personal income, which in turn limits the time they devote to science itself.” Generally 
speaking, the lack of rules, their inadequate enforcement and ineffective administrative processes 
that creates fertile ground for opportunistic behaviour of actors involved on both sides represent 
a major impediment for formal public-private collaboration. 
 
Intellectual property rights, technology transfer and market for technology 
 
Formal methods of intellectual property rights (IPRs) protection, in particular patents and their 
licensing, are underutilized, as clearly shown by European Commission (2012), in spite of the 
continuous effort to improve the use of public R&D outputs in innovation processes and despite 
the fact that state of the art IPRs legislation is in place. Yet few experts and little experience can 
be found in this field, especially in the public sector, except only perhaps of a few exceptions 
under the umbrella of ASCR that prove the rule. Poor commercialisation of R&D outcomes in 
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general requires systematic attention as well as support to research excellence to produce high 
valuable research outcomes being worth of patenting costs. 
 
Furthermore, there is a lack of organisations supporting knowledge transfer in practice. Supply 
of mediation services provided to innovative companies is insufficient. There are unfavourable 
conditions, including legal impediments, for setting up academic spin-offs. Technology Transfer 
Offices are in infancy in the public sector, as the results of which there is insufficient experience 
on how to trade patens and licenses on the market for technology. Knowledge transfer 
incentives are usually set through internal payroll regulations and other internal regulations 
defining remuneration of researchers including extraordinary bonuses related to successful 
transfers, patents, licences etc. However, these practices differ by organization, thus there are no 
generally accepted standards of behaviour. Systematic solution of the technology transfer issues 
at the national level, hence an explicit national knowledge transfer policy, is lacking.   
 
Sustainability of new large R&D infrastructures  
 
Large R&D infrastructural projects that are currently under construction with the support from 
the EU Structural Funds, for more information see Section 2.5 on Research and innovation 
system changes; provide a major promise for boosting the research output. However, the new 
projects represent a major funding puzzle, because the EU support is for the initial investment 
only. Later on, wage, maintenance and other operating expenses must be covered from other 
sources. So there is a tangible danger that these large projects turn from blessing to a curse for 
the public R&D system, as sizeable opportunity costs are likely to appear in not too distant 
future. Managers of the projects pledge to obtain funding from private sources. But this is likely 
to cover only a fraction of their needs. More likely is that their operating costs will start draining 
public R&D funding from the existing infrastructure. Unless the government noticeably expands 
outlays for R&D, which is not likely to happen in the near future, there could painful tradeoffs at 
stake. Either the new projects or the existing infrastructure might need to shrink; possibly quite 
significantly. And in the final analysis this can have major disruptive impact for functioning of 
the national innovation system. 
 
Another critical bottleneck for their success that should be mentioned is availability of qualified 
human resources, not to mention star scientists, on the labour market. Arguably, this is can turn 
out to be a major problem in some of the large research centres, as the expected demand by far 
exceeds domestic supply in the relevant scientific fields. Some of the new staff will have to be 
poached from the existing infrastructure. Some of them, perhaps even their majority, will have to 
come from abroad. But attracting large numbers of top foreign researchers in a relatively short 
span of time required for launching the full operation of the projects is not going to be easy, if 
one considers the above mentioned funding uncertainties, because of the fact that the wage level 
of scientist is far below the European average and in projects located far from the capital city of 
Prague, which proved to be attractive location for foreigners by itself. 
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HUMAN RESOURCES 
 
 
New doctorate graduates (ISCED 6) per 1000 population aged 25-34 
 
1.3 
Percentage population aged 25-34 having completed tertiary education 
 
20.4 
Open, excellent and attractive research systems 
 
 
International scientific co-publications per million population 
 
497.5 
Scientific publications among the top 10% most cited publications worldwide as % of total 
scientific publications of the country 
486.0 
Finance and support 
 
 
R&D expenditure in the public sector as % of GDP 
 
0.58 
FIRM ACTIVITIES 
 
 
R&D expenditure in the business sector as % of GDP 
 
0.97 
Linkages & entrepreneurship 
 
 
Public-private co-publications per million population 
 
24.7 
Intellectual assets 
 
 
PCT patents applications per billion GDP (in PPS€) 
 
0.93 
PCT patents applications in societal challenges per billion GDP (in PPS€) (climate change 
mitigation; health) 
0.14 
OUTPUTS 
 
 
Economic effects 
 
 
Medium and high-tech product exports as % total product exports 
 
62.1 
Knowledge-intensive services exports as % total service exports 
 
38.0 
License and patent revenues from abroad as % of GDP 
 
0.06 
 
Note: The latest year available. 
Data Source: European Commission (2012). 
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4 ASSESSMENT OF THE NATIONAL 
INNOVATION STRATEGY 
 
 
4.1 National research and innovation priorities 
 
National RDI Policy of the Czech Republic 2009–2015 (CRDI, 2009) is the central policy 
document, the elaboration of which has reflected a growing need to possess a strategic 
document, which would fully encompass the entire sector of research, development and 
innovation, and which would substitute various partial strategies concerning that preceded it. 
CRDI (2009) has been developed in the process implementation of The Reform of the RDI 
system in the Czech Republic (CRDI, 2008a), which was approved by the Government in 2008.  
 
National RDI Policy consists of nine main objectives: 
 Establish a strategic management of RDI at all levels based on systematic impact 
assessment of the National Policy as well as analyses of RDI; 
 Target the public support to RDI in line with demands of sustainable development; 
 Increase the efficiency of the public support to R&D; 
 Utilize the R&D results in innovation processes and enhance the co-operation of the 
public and private sector in RDI; 
 Intensify the involvement in the international RDI co-operation; 
 Provide qualified human resources for RDI; 
 Create an environment stimulating RDI; 
 Ensure the compatibility and linkages of the National Policy with other sectoral 
policies; 
 Ensure consistent evaluation of the RDI system. 
 
New R&D programmes developed under the new RDI policy were supposed to follow the 
Priorities of the Applied Research, Development and Innovation for 2009-2011 (CRDI, 2008b). 
However, the reality was rather different. The identified priorities were considered to be too 
broad; their set up had covered almost all science and research fields and their application into 
the subsequent research programmes did not function well. Hence, in 2012, the priorities were 
updated in the document National Priorities of Oriented Research, Experimental Development 
and Innovation (CRDI, 2012b), which sets new long-term national priorities of oriented RDI for 
the period until 2030 in six areas as follows:  
 Knowledge Economy 
 Energy 
 Natural Resources 
 Social Sciences 
 Health 
 Security Research 
 
The Priorities of Oriented Research (unlike the previous Priorities of Applied RDI) reflect major 
societal challenges and needs of the society as concrete goals solvable through RDI in available 
capacities and are set for the 15-20 years’ time horizon. Neither of these documents, however, 
set any binding or quantified targets for the given priorities. The new priorities should be 
respected in providing public RDI support, including designing new programmes and providing 
institutional support. The priorities will also be taken into account during the update of the 
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National RDI policy and the preparation of proposal of state budget expenditures in the 
following years. Responsibility for the process of priority setting lies with the CRDI.  
 
The Government adopted a comprehensive long-term Strategy of International Competitiveness 
in 2011 (MIT, 2011a), which addresses issues relevant to innovation performance in a broad 
sense given by improving the environment (regarding institutions, infrastructure, education, 
financial market, etc.) rather than by a simple financial support to innovation. The core of the 
Strategy called “3i” deals with institution, infrastructure and innovation – the three pillars which 
are frequently indicated as the main weaknesses of the present system (see e.g. lack of trust 
among actors, insufficient support to excellence in research, poor commercialisation effort and 
unavailability of venture capital). Concrete goals of the Strategy in respect to innovation are: 
 To increase the demand for innovation; 
 To increase awareness and motivation for cooperation between research institutions 
and the business sector; 
 To create financial, material and personnel conditions for the development of excellent 
research; 
 To target the public support to business and research primarily in respect to the 
identified key technology areas; and 
 To create a functional system for effective management of development policies and 
support instruments for innovative businesses and R&D. 
 
In parallel, the National Innovation Strategy (MIT, 2011b) was coproduced by the MEYS and 
the MIT and approved by the Government in 2011. It develops in more comprehensive way the 
innovation pillar of the Strategy of International Competitiveness. MIT (2011b) provides an 
overview of the innovation field and contains various measures divided into four main priority 
axes: excellent research; cooperation between business and research sector and knowledge 
transfer; innovative entrepreneurship; and human resources for innovation.  
 
ERAWATCH country reports (2010 and 2011) identified policy mix routes covering the major 
ways of increasing public and private R&D expenditures that remain highly relevant as follows: 
1. Promoting the establishment of new indigenous R&D performing firms;  
2. Stimulating greater R&D investment in R&D performing firms;  
3. Stimulating firms that do not perform R&D yet;  
4. Attracting R&D-performing firms from abroad;  
5. Increasing extramural R&D carried out in cooperation with the public   sector or other 
firms; and  
6. Increasing R&D in the public sector.  
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Table 1: Importance of routes in the national policy and recent changes  
Route 
Short assessment of the 
importance of the route in the 
national policy 
Main policy changes since 2009 
1 
Important, but relatively small in 
terms of budgetary weight. 
The major use of EU Structural Funds is to support business 
R&D. New measures (e.g. pre-seed fund supported by the OP 
RDI) should be launched in 2013 with the implementation of the 
Strategy of International Competitiveness. Tax measures to 
maintain the company conducting the R&D will be extended on 
buying external R&D yet. 
2 
Very important, also in terms of 
budgetary weight (via OP Enterprise 
and Innovation). 
Through the TIP programme allocates the MIT support to 
companies that carry out R&D. More interest to this route has 
been devoted through the Alpha programme requiring co-
financing by enterprises, which is a traditional mean how to 
stimulate private investment to R&D. Also parts of the OP EI 
are relevant to this issue.  
3 
Relatively high importance but 
relatively small in budgetary weight. 
The TIP programme as well as the Alpha programme is open to 
enterprises that have never performed R&D, but there is no 
special attention paid to R&D beginners in any support measure 
in the Czech Republic.  
 
4 
Important, but relatively small in 
terms of budgetary weight. 
The investment incentives run under the MIT through 
CzechInvest Agency have recently oriented to attract more R&D 
intensive investments. Tax incentives for the implementation of 
R&D activities can be also used by firms abroad operating in the 
Czech Republic. 
5 
Very high importance (included in 
almost all policy documents in the 
field of R&D). 
There are large support measures advantaging co-operation of 
particular project partners. Especially new programme 
Competence Centres launched by the TA CR focuses on a long-
term partnership of research organisations and business sector. 
Also large R&D infrastructures should foster science-industry 
links. 
6 
One of the most important routes, 
building the research capability has 
been a long term policy goal. 
Especially, utilisation of OP RDI represents significant bulk of 
money that could enhance R&D performed in the Czech public 
sector. The projects of new research capacities have been 
currently realised, thus their real impact is not evident yet. 
 
Source: ERAWATCH country reports (2010 and 2011). 
 
 
 
4.2 Evolution and analysis of the policy mixes 
 
The main body responsible for the formulation and coordination of the Czech RDI policy is the 
CRDI. At the implementation level, two ministries are the main institutions responsible for RDI 
issues: the MEYS (mainly academic research) and the Ministry MIT (industrial research and 
innovation). These two ministries are not the only institutions dealing with RDI issues. There are 
also other ministries with their own RDI budget, but their influence on overall RDI policies is 
rather minor. Their number has been reduced to five plus the two mentioned above with the 
implementation of the ongoing reform of the RDI system. All the ministries with RDI budget 
have also some conceptual documents dealing with RDI policy in their respective sectors.  
 
In recent years, the government has started being much more active in promoting and 
supporting cooperation of private and public bodies in R&D. The current set of measures puts 
greater emphasis on technology transfer and co-operation between research institutes and private 
companies at the first place. In other words, the effort is to gain a more intensive inclusion of 
the private sector into joint public-private research projects. This shift is connected also with a 
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sounder support to R&D in businesses and private enterprises. These measures are to increase 
the private expenditures on RDI and facilitate diffusion of new technologies in enterprises.  
 
The support programmes are either financed from the Operational Programme Enterprise and 
Innovation (the sub-programmes called Innovation, Potential, Cooperation and ICT and 
Strategic Services), or programmes funded mainly from the national sources and administered by 
the Ministry of Industry and Trade (IMPULS, TANDEM and TIP). All of the programmes are 
focused on support of industrial R&D and collaboration of enterprises with research institutions. 
Programmes administered by the Technology Agency of the CR (Alpha, Centres of 
Competence) also emphasize strengthening collaboration between public research institutes and 
private sector as one of their main goals. Also, the Ministry of Education, Youth and Sports 
currently carrying out a project called EF-TRANS; its goal is to set up and bring into effect 
knowledge transfer between R&D institutions and industry. A simple system of knowledge 
transfer is being created, with a special emphasis on patent and licenses applications, intellectual 
property, establishment of spin-offs, and active cooperation between research institutions and 
industry. 
 
In recent years, new measures were introduced, which are visibly shifting to make public support 
bound to the collaboration with industry and use of research results. This trend has been evident 
since the National RDI Policy was approved in 2009, where one of the objectives was to 
condition public support through the R&D programmes by collaboration of public research 
organisations with users of R&D, based on co-financing from public and private sources. Some 
new programmes go even further, requiring an application of R&D results in practice. The latter 
is the case of programmes designed and implemented by the TA CR, which supports applied 
research, collaboration between research and application sphere and transfer of knowledge. The 
“new wave” of R&D programmes introduced by the TA CR in operation since 2011 or 2012 
includes: 
 
1. The programme called ALPHA - supporting projects of applied research and 
experimental development and stimulating intensity and effectiveness of R&D 
cooperation between businesses and research organisations. 
2. The BETA programme - a programme of public procurement in research, experimental 
development and innovation for the needs of public administration bodies.  
3. The OMEGA programme supporting research in applied social sciences. 
4. Competence Centres supporting creation and operation of research, development and 
innovation centres for progressive fields with strong application potential and a 
perspective for significant contributions to the growth of the competitiveness of the 
Czech Republic.  
 
The programme TIP administered by the MIT supports applied industrial research and R&D 
collaboration of the business and academic sectors. A set of new instruments within OP EI has 
been introduced with a support from the EU structural funds 2007-2013. These programmes are 
launched and managed by the CzechInvest agency. This set of programmes is designed to 
address needs of industrial enterprises from start-ups to mature supporting their development 
and R&D. Most relevantly, the Potential programme supporting the creation of R&D capacities 
in enterprises and formalised alliances between companies is aimed at increasing the 
competitiveness of business. Another relevant programme called Cooperation supports 
technology platforms and clusters.  
 
The RDI policy does not stand alone, thus other policies touching directly or indirectly the issue 
should be mentioned. Human resources policies with relevance for R&D are currently 
represented within the educational policy. These measures focus on increasing the attractiveness 
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of research careers and research as such. Apart from several smaller local initiatives, the most 
prominent among these is the Česká hlava (Czech Head) project which awards an annual prize to 
distinguished Czech scientists for their life-long achievement. Recently this award was also 
extended to include awards for talented secondary school students.  
 
In addition, two-year projects supported by the EU structural funds entitled Otevrená veda 
(Open Science) and Otevrená veda regionum (Open Science for Regions) were launched by the 
Czech Academy of Science in 2005 and 2007 respectively. The former project was prolongued 
for period 2009-2012 as Otevrena veda II. Both projects target primarily secondary school 
teachers and their students and aim to assist teachers in directing students to research careers and 
making the curricula of secondary school science more attractive.  
 
More activities aimed at increasing the attractiveness of research careers and popularising 
research are planned in some of the OPs relevant to research ("soft" measures, such as science 
and technology popularisation courses under OP EC and "hard" measures, such as development 
of science learning centres under OP RDI). A new measure called NÁVRAT (RETURN) aimed 
to improve conditions for re-integration of top researchers coming back from abroad was 
launched under the MEYS in 2011 and the first projects have been supported in 2012. The 
MOBILITY programme is focused on outwards mobility of researchers supporting short-term 
internships at foreign partner institutions. Bilateral mobility of students and university teachers 
and researchers is funded by the MEYS and financial resources from Structural Funds. The 
Czech Republic also has access to the Fulbright Fellowship Program, which supports studying, 
teaching and researching in the United States.  
 
Since 2005 the Czech government has also adopted a number of strategic documents which aim 
to facilitate the integration of immigrants. Although the proposed measures are general 
immigration measures, they may have a positive effect on the immigration of foreign R&D 
workers. At the end of 2007 the Czech Parliament started the debate over the amendment of 
Czech Immigration Act as a reaction to the EU legislation (transposition of EC Directive 
2005/71 on a specific procedure for admitting third-country nationals for the purposes of 
scientific research). As a result, an amended law was passed before the end of 2007 which allows 
a specific regime (lower administrative burden and shorter procedures) for legal stay of 
researchers of foreign origin. This law only applies to foreign nationals employed at universities 
and public research organizations. Inward flows of researchers are supported also by the 
EURAXESS network (a part of the European Services Network / EURAXESS) funded by the 
MEYS, which provides information support to incoming researchers, advice and assistance on 
visa procedure, social security, taxes and other practical aspects of everyday life. MEYS also runs 
a grant programme intended for talented Master and PhD students coming from third countries 
and studying in public universities. 
 
Also the involvement of the the Ministry of Finance has to be mentioned as tax incentives to 
deduct expenditures on R&D carried out in-house were introduced in 2005. An extension of the 
current tax incentives scheme for R&D is expected in the near future, when research purchased 
from research organisations will be also deductible from the tax base. According to the Ministry 
of Finance, the effect on private R&D investment is quite substantial, at least in terms of creating 
an incentive for businesses to report their actual R&D expenditure. The practical implementation 
of this fiscal measure is, however, complicated by confusion over the practical interpretation of 
the regulation.  
 
The existing methodological guideline from the MF is criticised by businesses since it leaves 
scope for different interpretation as to what should and what should not be included in the R&D 
expenditure. The complaints from the business sector are addressed mainly to the lack of 
  25 
awareness at the level of local tax offices who often apply an unnecessarily strict interpretation of 
the regulation. Anecdotal evidence from individual businesses suggests that this administrative 
hurdle (repeated controls from local tax offices) could de-motivate firms from applying the tax 
deduction in the future. It has been recognized, furthermore, that the current form of tax 
deduction is going against the need to intensify collaboration between the business sector 
academia. Hence, expenditure on external R&D services (contract research) is also going to 
become the subject to this exemption in near future.  
 
Commercialisation of R&D results and transformation of new knowledge into innovation is 
hindered by insufficient utilisation of instruments for IPR protection. However, this situation has 
been changing through the implementation of the National RDI Policy 2009-2015. Together 
with the establishment of the TA CR implementing support for applied research greater 
emphasis is put on the programmes supporting innovation activities and cooperation of the 
academia and industry.  
 
Attention to fostering science-industry links is paid also in several operational programmes. This 
concerns mainly the OP EI and its priority 4 - Innovation and priority 5 - Environment of 
Entrepreneurship and Innovation. The OP RDI also includes several research-innovations and 
academia-industry links support measures. These include mainly support of commercialisation of 
R&D outputs in research institutions, in particular by financing the stage from R&D information 
up to the stage of the subsequent commercial use (proof of concept stage) and support of the 
commercialisation system and intellectual ownership protection, including the establishment and 
development of technology transfer offices by research organisations. 
 
 
4.3 Assessment of the policy mix 
 
The main innovation policy targets as announced in the key policy documents (National Reform 
Programme, Reform of the Czech RDI system and the National RDI Policy 2009–2015) are 
consistent with the current needs for improvement of the national innovation system. However, 
the present RDI system can be assessed as inadequate in terms of effectiveness, flexibility and 
appropriateness of research and innovation governance, which results inter alia in the insufficient 
quality of R&D results and the detachment of public research from industrial and societal needs. 
The main reason lies in the remaining fragmentation of RDI governance in the Czech Republic. 
Creation of one central coordination body responsible for research, development and innovation 
is among activities of the Reform of the RDI System and of the national RDI policy, but the 
implementation of this task remains to be a challenge. 
 
The reason for production of R&D results of a doubtful quality relies in the insufficient support 
for the excellent research and low evaluation standards. Higher efficiency of the public support 
system achieved also through more effective evaluation of R&D is one of the main goals of the 
RDI policy. However, evaluation methodology remains the challenge for the policy makers as 
stated in the International Audit of Czech RDI. More generally, evaluation is rather 
underestimated issue in the Czech Republic. Present “evaluations” of research programmes are 
highly formalised (including only quantitative formulation of the results achieved) and they do 
not provide any additional information for policy makers. Similarly, assessment of R&D 
programmes regarding development of relevant science fields or industry sectors or grasping 
societal needs cannot be achieved within the present framework. Also systematic evaluation of 
research organisations is missing in the Czech Republic. According to the RDI policy, a new 
methodology for the evaluation of research results should be elaborated taking into account 
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some new components (e.g. training of graduates, dissemination of R&D results, technology 
transfers etc.) and not only research outputs as it is the case now. 
 
Nonetheless, some shortcomings in the RDI system have been addressed in the current in-depth 
Reform of the Czech RDI system. Particularly the establishment of TA CR and reduction of 
budgetary chapters has contributed to the improved coordination of targeted R&D funding and 
de-fragmentation of R&D public support. Some of the existing RDI programmes have 
encouraging effects on innovation activities in the business sector. More intensive inclusion of 
the private sector in joint public-private research projects seems to be promising as new R&D 
programmes have been introduced by the TA CR, but evidence on the effectiveness of the new 
programmes is not available yet. Generally speaking, the current innovation policy mix is largely 
addressing the identified challenges, but the outcomes are yet to be seen. 
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Challenges 
Policy 
measures/actions 
Assessment in terms of appropriateness, efficiency 
and effectiveness 
Inefficient use of 
public funds for 
supporting R&D 
and innovation 
New methodology for 
evaluation R&D 
results and R&D 
organisations 
To tackle this problem, it is necessary to introduce of a 
complex methodology for evaluation of R&D results; 
the current one based predominantly on quantitative 
indicators has been identified as unsatisfactory; the 
necessity to update the evaluation methodology has 
been emphasized in the International Audit of Czech 
R&D; however, the revision requires consensus of the 
key players in the national R&D system, which proved 
extremely difficult. 
Lack of external 
financial resources 
for innovation 
OP EI 
Planned establishment 
of the pre-seed fund 
(TA CR has been established in 2009 as the dominant 
supporter of applied research and launched a portfolio 
of new programmes; two programmes of the OP EI, 
Progress and Guarantee, help start-ups and micro 
enterprises to overcome the limited availability of 
external funding; however, availability of venture 
capital remains one of the lowest among EU27 
countries; the MIT announced plans to establish a 
public seed fund to boost the access to venture capital. 
Lack of 
cooperation 
between research 
and business 
sector 
OP RDI 
Alpha, TIP, 
Competence Centres 
OP EI 
(OP RDI supports building of the infrastructure for 
excellent fundamental and applied research and 
infrastructure for transfer of R&D knowledge; 
clustering activities are supported through the OP EI; 
there are new national R&D programmes that motivate 
enterprises to cooperate with research organisations in 
common projects; however, results of these 
programmes have not materialized in more intensive 
cooperation so far. 
Protection of 
intellectual 
property rights 
(IPRs) is 
underutilized and 
hence market for 
technology 
underdeveloped 
Realisation of the 
Reform 
Alpha, Competence 
Centres 
OP EI 
Among the top objectives of the Reform of the RDI 
System is to improve the commercialization of R&D 
outputs on the market for technology and innovation 
processes at large; new R&D support programmes, 
such as Alpha and Competence Centres launched by 
TA CR, require the utilization of R&D results and 
motivate the participants to acquire IPRs; the sub-
programme of the OP EI called Innovation enables 
beneficiaries to use the grant on IPRs; however, the 
number of international patents per capita remains low. 
Future funding of 
new large R&D 
infrastructures 
OP RDI 
Six major infrastructural projects are under 
construction with the support from the OP RDI. After 
five years, their operating expenses must be covered 
from other sources. Private funding is likely to cover 
only a small fraction. Unless the government 
significantly expands the amount of public R&D 
support, there could be painful tradeoffs at stake. 
Either the new projects or the existing infrastructure 
might need to shrink. It is not clear how this situation 
is going to be resolved. 
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5 NATIONAL POLICY AND THE EUROPEAN 
PERSPECTIVE 
 
Overall, despite the problems cited above, the policy mix is on the right track, aiming at the main 
challenges. The RDI reform has stimulated much needed public debate on the role of research 
for competitiveness and the development of the society at large. A number of strategic 
documents have been published in recent years that for the first time outlined the RDI policy in 
a coherent, compact and comprehensive manner. As the result, the key stakeholders become 
increasingly aware of the challenges and there seems to be slowly emerging consensus on the way 
forward.  Nevertheless, in many respects the progress has been slow and if the problems are not 
successfully tackled in near future the goals underlying the reform are not likely to be achieved. 
 
Governance coordination issues, the revision of evaluation methodology and more effective 
allocation of public institutional funding are the top priorities. The CRDI that has assumed a 
central role in the new governance system needs to be provided with resources that allow it to 
live up to this task. The GA CR and TA CR that has become responsible for competitive 
funding should be further strengthened to mitigate the fragmentation of support programs and 
overlaps in measures striving to attain the same target. The priorities of oriented RDI that have 
been revised provide more specific guidelines for thematic funding than used to be the case, as 
the results of which the volume of funding targeted on the specific themes is expected to 
gradually grow.  
 
One aim that has been repeatedly stressed in the recent policy documents is promoting 
excellence in research. But this has been grossly mismanaged by the formula-based system of 
evaluation that annually reallocates the entire flow of institutional funding based solely on 
historical output scores. In line with the recommendations by Arnold (2011), a project launched 
under the auspice of MEYS is preparing a new more complex evaluation methodology of 
research institutions and allocation of public institutional funding; however, the results remain to 
be seen.  Another closely related challenge that is looming on the horizon is to secure funding 
for operation of the newly constructed large R&D infrastructure projects, which is likely to send 
ripples throughout the public research sector. Overall, the public R&D funding needs to increase 
in order to reach the national target of 1% of GDP in Europe 2020 initiative. 
 
Despite a number of newly introduced measures designed to strengthen the public-private 
interface, the commercialization of publicly funded research into innovative solutions in the 
business sector remains a constant challenge. MIT (2011a,b) dealing with this issue explicitly 
mentions the need to stimulate the so far very limited demand for innovation in the domestic 
business sector. The strategy proposes support for development of relevant business innovation 
services and suggests a long list of concrete actions, including the establishment of a pre-seed 
fund, knowledge transfer partnership programme, support for technology transfer services, 
public R&D procurement, amendment of the tax law and support for regional innovation; some 
of which have already started to be implemented. Nevertheless, the support is fragmented, 
scattered in a number of small programs. IPRs continue to be grossly underused. Admittedly, 
there is an urgent need for a comprehensive national knowledge transfer policy, including a new 
legislation on technology transfer, which tackles this challenge in a systematic way. 
 
Another major policy shift that needs to be applauded has been from a system traditionally based 
on direct public subsidies to RDI in the business sector towards introducing much wider 
portfolio of measures aimed at alleviating the problem of insufficient availability of funding for 
private R&D efforts; many of which target the type of applicants, such as small and new firms, 
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that typically do not use the direct grants. The indirect fiscal support through R&D tax credits, 
which has gradually expanded in recent years, is planned to be further extended to purchase of 
external research services, hence this is also going to stimulate the public-private linkages. Access 
to venture capital that is well-known to be particularly problematic is planned to be addressed by 
the establishment of a public seed fund, which is expected to start operation sometimes soon. 
Several regions have implemented innovation voucher programmes, albeit the resources devoted 
to this instrument have been very small so far. More measures that go beyond the direct 
subsidies are clearly desirable in the future. 
 
Labour market for researchers continues to suffer from a lack of experts. Human resources 
management practices in the public sector need to be revised in order to reduce the widespread 
in-breeding, make career progression paths more transparent and intensify competition for posts. 
Arnold (2011) points to the fact that less than 10% of researchers are foreign and half of those 
are Slovaks, which is very small proportion by international standards. There is a considerable 
scope for making better use of research internationalization in the public sector, the limited 
extend of which is in a sharp contrast to the pivotal role of foreign affiliates in the business 
sector. An explicit internationalization strategy of the public research system is lacking. 
 
 
Generally speaking, the national policy mix is aligned with the main ERA’s objectives, however, 
at the same time it should be clear from the analysis above that is some areas the progress falls 
short of expectations. Much attention has been recently devoted in the RDI reform agenda to 
making the national research system more effective and leaving the dysfunctional mechanism for 
allocating institutional funding, which is currently under revision, aside, a noticeable progress has 
been made in streamlining the funding system, increasing the share of public funding allocated 
on a competitive basis and pinpointing sensible priorities of oriented research that are largely in 
line with the grand challenges. Several large R&D infrastructural projects, including pan-
European infrastructures, are under construction, which have a potential to both open new 
avenues for internationally co-operation and make the system more competitive. Nevertheless, a 
lot remains to be done in improving labour market for researchers and in fostering gender 
equality in research, particularly as far as limited mobility, internationalization, early career 
opportunities and rigid recruitment practices are concerned. Needles to say, major challenges 
remain to be tackled in the domain of circulation, access and transfer of scientific knowledge, 
which has been historically weak aspect of the system, and which hinders public-private 
collaboration. 
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Assessment of the national policies/measures supporting the strategic ERA objectives 
(derived from ERA 2020 Vision) 
ERA 
dimension 
Main challenges at national level Recent policy changes 
Labour Market 
for Researchers 
Labour market for researchers still suffers 
from lack of researchers mainly in the S&T 
fields. 
International mobility is considered as one of 
the main challenges for improvement. 
low attractiveness of a research career in the 
CR for foreigners due to lower salaries of 
researchers in comparison with the EU-15 
countries . 
 Issue reflected in National RDI 
Policy and in the Reform as a high 
priority. 
 OP Education for 
Competitiveness and OP Human 
Resources and Employment 
support measures. 
 New schemes supporting inward 
as well as outward (short-term) 
mobility of researchers. 
Cross-border 
cooperation 
Low awareness of researchers about the 
international research programmes leading to 
a low participation of Czech teams in the 
international activities in the field of 
research. 
 Issue addressed in the national 
RDI policy as a priority. 
 FP7 Cooperation – international 
teams common projects. 
 Czech participation in Eureka, 
COST etc. 
World class 
research 
infrastructures 
There is a number of projects supporting the 
development of research infrastructures 
from the EU Structural Funds, but there is a 
question remaining on the sufficient number 
of researchers for these new infrastructures. 
 Approval of the Roadmap for 
Large Research, Development and 
Innovation Infrastructures in the 
Czech Republic by the 
Government in March 2010  
 OP RDI Priority Axis 1 + 2: 
support to centres of excellence 
and regional R&D centres. 
Research 
institutions 
ASCR and universities are quite autonomous. 
Third role of universities shall be supported 
by the reform of tertiary education. There is 
low participation of stakeholders (mainly 
from industry) in university management 
boards. 
 
 Institutes of the ASCR have 
become autonomous / 
independent public research 
institutions including their 
financial responsibility.  
 The methodology of HEIs and 
PROs evaluation and the system 
of institutional funding based on 
the evaluation has been deemed 
unsatisfactory and is under a 
revision.   
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ERA 
dimension 
Main challenges at national level Recent policy changes 
Public-private 
partnerships 
Several R&D programmes supporting 
research-industry collaboration has been 
launched but there is a lack of organisations 
ensuring technology & knowledge transfer 
into practice. Insufficient supply of 
mediation services provided to innovative 
companies and unfavourable conditions for 
setting up academic spin-offs. Low support 
to private-public mobility of researchers. 
 Issue addressed in the national 
RDI policy as a priority 
 New programmes of TA CR 
(Alpha, Centres of Competence) 
and the Ministry of Industry and 
Trade (TIP) supporting co-
operation between PROs and 
private sector  
 OP RDI Priority Axis 3 aiming at 
support of the commercialisation 
of research results including the 
technology transfer offices.  
Knowledge 
circulation 
across Europe 
National and European funding enabled the 
development of science parks, incubators, 
TTOs, but also qualified human resources 
for the technology transfer are still a 
challenge to support the knowledge 
circulation across Europe.   
 MEYS is supporting the return of 
Czech researchers after experience 
from abroad through a 
programme called NAVRAT.  
International 
Cooperation 
Concerning the international cooperation, 
FPs are the most significant programmes. 
The participation of Czech industry in FP7 is 
relatively high, but the Czech universities lag 
behind the EU average. Participation in 
COST, EUREKA, CERN and other 
international programmes is not very well 
monitored. 
  
 New measures supporting 
international co-operation in 
applied research  
 Support programmes of bilateral 
international R&D cooperation, 
such as KONTAKT, GESHER 
and MOBILITY.  
 
Source: ERAWATCH country report (2012). 
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LIST OF ABBREVIATIONS  
 
 
ASCR Academy of Sciences of the Czech Republic 
BERD Business Expenditure on Research and Development 
CERN European Organisation for Nuclear Research 
COST European Cooperation in Science and Technology 
CR Czech Republic 
CRDI Council for Research, Development and Innovation  
CZK Czech koruna 
ELI Extreme Light Infrastructure  
ERA European Research Area 
ERDF European Regional Development Fund 
ESF European  Social Fund 
ESFRI European Strategy Forum on Research Infrastructures 
ESO European Southern Observatory  
EU European Union 
EU27 European Union including 27 Member States 
FP European Framework Programme for Research and Technology Development 
FP7 7th Framework Programme 
GA CR Grant Agency of the Czech Republic = Czech Science Foundation 
GBAORD Government Budget Appropriations or Outlays on R&D 
GDP Gross Domestic Product 
GERD Gross Domestic Expenditure on R&D 
HEI Higher education institutions 
ICT Information and Communication Technologies 
IPR Intellectual Property Rights 
MEYS Ministry of Education, Youth and Sports of the Czech Republic 
MIT Ministry of Industry and Trade of the Czech Republic 
NABS Nomenclature for the Analysis and Comparison of Scientific Programmes and 
Budgets 
NIS National Innovation Strategy 
OP 
OP EI 
OP RDI 
PROs 
Operational Programme  
Operational Programme Enterprise and Innovation  
Operational Programme Research and Development for Innovation 
Public Research Organisations 
R&D Research and development 
RDI Research, Development and Innovation 
RIS3 Research and Innovation Strategy on Smart Specialisation 
S&T Science and Technology 
TA CR Technology Agency of the Czech Republic 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
European Commission 
EUR 26271 – Joint Research Centre – Institute for Prospective Technological Studies 
 
Title: ERAWATCH Country Reports 2012: Czech Republic 
 
Authors: Martin Srholec based on the 2011 Country Report by Lenka Hebáková, Jan Vanžura and Miroslav Kostić 
 
Luxembourg: Publications Office of the European Union 
 
2014- 34 pp. – 21.0 x 29.7 cm 
 
EUR – Scientific and Technical Research series – ISSN 1831-9424 (online)  
 
ISBN 978-92-79-38636-7 (pdf) 
 
doi:10.2791/84961 
 
 
 
Abstract 
This analytical country report is one of a series of annual ERAWATCH reports produced for EU Member States and Countries Associated 
to the Seventh Framework Programme for Research of the European Union (FP7). The main objective of the ERAWATCH Annual Country 
Reports is to characterise and assess the performance of national research systems and related policies in a structured manner that is 
comparable across countries. 
The Country Report 2012 builds on and updates the 2011 edition. The report identifies the structural challenges of the national 
research and innovation system and assesses the match between the national priorities and the structural challenges, highlighting the 
latest developments, their dynamics and impact in the overall national context. They further analyse and assess the ability of the policy 
mix in place to consistently and efficiently tackle these challenges. These reports were originally produced in December 2012, focusing on 
policy developments over the previous twelve months. 
The reports were produced by independent experts under direct contract with IPTS. The analytical framework and the structure of the 
reports have been developed by the Institute for Prospective Technological Studies of the Joint Research Centre (JRC-IPTS) and 
Directorate General for Research and Innovation with contributions from external experts. 
 
  
 
 
As the Commission’s in-house science service, the Joint Research Centre’s mission is to provide EU policies with 
independent, evidence-based scientific and technical support throughout the whole policy cycle. 
 
Working in close cooperation with policy Directorates-General, the JRC addresses key societal challenges while 
stimulating innovation through developing new standards, methods and tools, and sharing and transferring its know-
how to the Member States and international community. 
 
Key policy areas include: environment and climate change; energy and transport; agriculture and food security; health 
and consumer protection; information society and digital agenda; safety and security including nuclear; all supported 
through a cross-cutting and multi-disciplinary approach. 
    LF-1
A
-2
62
7
1-EN
-N
 
doi:10.2791/84961 
ISBN: 978-92-79-38636-7 
